HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Joachim P Steinbach Selected Research
Joachim P Steinbach Research Topics
Disease
66
Glioblastoma (Glioblastoma Multiforme)
04/2024 - 05/2002
65
Neoplasms (Cancer)
02/2024 - 01/2002
59
Glioma (Gliomas)
05/2024 - 01/2002
22
Hypoxia (Hypoxemia)
08/2021 - 03/2004
15
Astrocytoma (Pilocytic Astrocytoma)
01/2023 - 05/2002
15
Brain Neoplasms (Brain Tumor)
09/2022 - 12/2005
7
Oligodendroglioma
05/2022 - 11/2004
5
Neoplasm Metastasis (Metastasis)
10/2023 - 01/2014
5
Starvation
08/2020 - 06/2009
4
Necrosis
02/2021 - 12/2016
3
Edema (Dropsy)
03/2017 - 12/2011
2
Lymphoma (Lymphomas)
02/2024 - 01/2021
2
Hydrocephalus (Hydrocephaly)
10/2023 - 08/2018
2
Meningioma (Meningiomas)
09/2022 - 11/2017
2
Disease Progression
05/2022 - 01/2019
2
Cytopenia
01/2022 - 12/2010
2
Thrombocytopenia (Thrombopenia)
01/2022 - 07/2012
2
Hemorrhage
02/2021 - 11/2017
2
Ketosis
11/2020 - 08/2018
2
Epilepsy (Aura)
11/2017 - 11/2017
2
Neuroepithelial Neoplasms (Gliomatosis Cerebri)
03/2017 - 09/2011
2
Medulloblastoma
11/2014 - 12/2010
2
Infections
06/2014 - 07/2012
2
Retinoblastoma (Glioblastoma, Retinal)
11/2004 - 11/2004
Drug/Important Bio-Agent (IBA)
27
Temozolomide (Temodar)
FDA Link
Generic
04/2024 - 12/2005
27
Bevacizumab (Avastin)
FDA Link
09/2023 - 09/2011
16
Proteins (Proteins, Gene)
FDA Link
05/2022 - 05/2002
14
ErbB Receptors (EGF Receptor)
IBA
10/2020 - 01/2002
13
Lomustine (CCNU)
FDA Link
08/2022 - 05/2002
11
TOR Serine-Threonine Kinases
IBA
01/2024 - 03/2004
11
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
01/2023 - 12/2009
11
Glucose (Dextrose)
FDA Link
Generic
11/2020 - 03/2005
10
Biomarkers (Surrogate Marker)
IBA
01/2018 - 12/2007
6
Methyltransferases
IBA
01/2024 - 09/2006
6
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 08/2007
5
Irinotecan (Camptosar)
FDA Link
Generic
08/2022 - 10/2016
5
Mechanistic Target of Rapamycin Complex 1
IBA
09/2019 - 01/2015
5
Caspases
IBA
01/2017 - 11/2004
5
Ligands
IBA
12/2016 - 01/2002
4
Adenosine Triphosphate (ATP)
IBA
11/2020 - 06/2009
4
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2020 - 02/2016
4
Epidermal Growth Factor (EGF)
IBA
08/2020 - 03/2015
4
Small Interfering RNA (siRNA)
IBA
03/2019 - 06/2009
4
Oxygen (Dioxygen)
IBA
01/2019 - 09/2012
4
O(6)-Methylguanine-DNA Methyltransferase
IBA
10/2016 - 03/2009
3
Ketone Bodies
IBA
05/2024 - 07/2011
3
Sirolimus (Rapamycin)
FDA Link
01/2024 - 06/2009
3
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2024 - 10/2017
3
Chimeric Antigen Receptors
IBA
11/2023 - 04/2016
3
Steroids
IBA
08/2022 - 03/2017
3
Immune Checkpoint Inhibitors
IBA
05/2022 - 11/2020
3
4- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazoline
IBA
10/2020 - 03/2004
3
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2020 - 02/2016
3
Messenger RNA (mRNA)
IBA
01/2019 - 05/2002
3
Anticonvulsants (Antiepileptic Drugs)
IBA
11/2017 - 02/2012
3
Teniposide (VM 26)
FDA Link
01/2016 - 09/2002
3
Death Domain Receptors
IBA
11/2004 - 01/2002
2
bafilomycin A1
IBA
10/2022 - 01/2014
2
MTOR Inhibitors
IBA
10/2022 - 09/2019
2
Amino Acids
FDA Link
09/2022 - 04/2016
2
Tyrosine (L-Tyrosine)
FDA Link
09/2022 - 01/2021
2
Protein Subunit Vaccines
IBA
05/2022 - 01/2021
2
Cisplatin (Platino)
FDA Link
Generic
01/2022 - 09/2002
2
Serine (L-Serine)
FDA Link
09/2021 - 01/2020
2
BAY 1436032
IBA
01/2021 - 10/2020
2
Ketones
IBA
11/2020 - 07/2011
2
alpha-hydroxyglutarate
IBA
10/2020 - 01/2019
2
Cetuximab (Erbitux)
FDA Link
10/2020 - 04/2016
2
Monoclonal Antibodies
IBA
10/2020 - 03/2015
2
epidermal growth factor receptor VIII
IBA
08/2020 - 04/2016
2
Angiopoietin-2
IBA
12/2019 - 01/2016
2
Doxycycline (Periostat)
FDA Link
Generic
01/2019 - 05/2018
2
Alkylating Agents
IBA
01/2018 - 12/2005
2
nimotuzumab
IBA
01/2018 - 03/2015
2
Ribosomal Protein S6
IBA
01/2018 - 03/2004
2
MicroRNAs (MicroRNA)
IBA
11/2017 - 11/2017
2
Phosphotransferases (Kinase)
IBA
05/2017 - 01/2016
2
LY-2157299
IBA
05/2017 - 01/2016
2
Transforming Growth Factors (Transforming Growth Factor)
IBA
05/2017 - 01/2016
2
ABT-737
IBA
01/2017 - 07/2010
2
Imatinib Mesylate (Gleevec)
FDA Link
07/2016 - 02/2010
2
Antigens
IBA
04/2016 - 11/2014
2
Nimustine
IBA
06/2014 - 03/2009
2
Enzymes
IBA
07/2012 - 07/2011
2
Fas Ligand Protein (Fas Ligand)
IBA
03/2005 - 01/2002
2
Inhibitor of Apoptosis Proteins
IBA
11/2004 - 11/2004
2
RTKI cpd
IBA
03/2004 - 01/2002
2
Antibodies
IBA
05/2002 - 01/2002
1
acetoacetic acid (acetoacetate)
IBA
05/2024
1
Cytarabine (Cytosar-U)
FDA Link
Generic
04/2024
Therapy/Procedure
55
Therapeutics
10/2023 - 01/2002
25
Radiotherapy
10/2023 - 11/2004
21
Drug Therapy (Chemotherapy)
09/2022 - 09/2002
6
Chemoradiotherapy
01/2022 - 11/2011
5
Ketogenic Diet
02/2022 - 07/2011
5
Re-Irradiation
02/2022 - 02/2009
2
Neurosurgical Procedures
10/2023 - 02/2012
2
Ventriculoperitoneal Shunt
10/2023 - 08/2018
2
Immunotherapy
05/2022 - 01/2019
2
Precision Medicine
11/2017 - 11/2017